ABCL Investor Relations (IR)
Official sources, filings and reporting dates for AbCellera Biologics Inc.
Official Sources
-
AbCellera Biologics Inc. investor relations →
investors.abcellera.com
-
Latest results release →
2026 Q2, published Aug 5, 2026
-
SEC filings on EDGAR →
10-K, 10-Q and 8-K filing history
Recent Results
-
2026 Q2 reported Aug 5, 2026Press release →
-
2026 Q1 reported May 11, 2026Press release →
-
2025 Q4 reported Feb 24, 2026Press release →
-
2025 Q3 reported Nov 6, 2025Press release →
Rule of 40
R40 scores AbCellera Biologics Inc. at 0 on its latest reported quarter, combining revenue growth with free cash flow margin.
See the score history →